An Anti-PSMA Bivalent Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Imaging and Therapy

Preclinical Evaluation of a Recombinant Anti-Prostate Specific Membrane Antigen Single-Chain Immunotoxin Against Prostate Cancer

(2010) Philipp Wolf et al.   JOURNAL OF IMMUNOTHERAPY

Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody

(2010) Kerstin Fortmüller et al.   PROSTATE

Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer

(2009) Chunsheng Liu et al.   PROSTATE

Systemic chemotherapy and new experimental approaches in the treatment of metastatic prostate cancer

(2008) C. N. Sternberg   ANNALS OF ONCOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1)

(2008) Jung Hee Woo et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Construction and Preliminary Investigation of a Plasmid Containing a Novel Immunotoxin DT390-IL-18 Gene for the Prevention of Murine Experimental Autoimmune Encephalomyelitis

(2008) Jing Jia et al.   DNA AND CELL BIOLOGY